33 results
PRE 14A
LRMR
Larimar Therapeutics Inc
12 Apr 24
Preliminary proxy
6:06am
and demographic background statistics for our Board. Each of the categories listed in the matrix below has the meaning given to it in Nasdaq Listing Rule 5605(f … Identity
Directors
Part II: Demographic Background
African American or Black
Alaskan Native or Native American
Asian
Hispanic or Latinx
Native Hawaiian
8-K
EX-99.2
LRMR
Larimar Therapeutics Inc
11 Mar 24
Other Events
4:09pm
provides industry with several key items Assistance with patient recruitment and education Access to Global Patient Registry with demographic … evaluating once-daily and every-other-day dosing regimens for CTI-1601
Phase 2 Demographic/ Disease Characteristics Data
Demographics – Phase 2
8-K
EX-99.2
LRMR
Larimar Therapeutics Inc
12 Feb 24
Results of Operations and Financial Condition
7:03am
items Assistance with patient recruitment and education Access to Global Patient Registry with demographic and clinical information on more than 1,000 FA
8-K
EX-99.2
jcoxg 3m1q4
14 Nov 23
Larimar Therapeutics Reports Third Quarter 2023 Operating and Financial Results
12:00am
8-K
EX-99.1
zjrfkp 5hm4nhr6oqi
14 Aug 23
Other Events
8:00am
8-K
EX-99.1
y5l3gjfwl
1 Jun 23
June 2023 Larimar Therapeutics Corporate Presentation
4:06pm
8-K
EX-99.2
9fuy 1q88
10 Nov 22
Larimar Therapeutics Reports Third Quarter 2022 Operating and Financial Results
7:01am
8-K
EX-99.1
taix7 y8m69
20 Oct 22
October 2022 Larimar Therapeutics Corporate Presentation
8:11am
8-K
EX-99.2
99e24k07766bgl
14 Sep 22
Other Events
7:05am
8-K
EX-99.2
ke1y2hafxntxy1nbw
11 Aug 22
Larimar plans to submit a complete response to CTI-1601’s clinical hold in the third quarter of 2022
4:13pm
8-K
EX-99.2
zbeqt2su6m ilwmoqvcg
12 May 22
Larimar Therapeutics Reports First Quarter 2022 Operating and Financial Results
7:12am
8-K
EX-99.2
hrb5rky52y3ns274
25 Mar 22
Larimar Therapeutics Reports Fourth Quarter and Full Year 2021 Operating and Financial Results
7:11am
8-K
EX-99.1
g36zub0gwzhjxvb 7k9
28 Feb 22
Results of Operations and Financial Condition
8:16am
8-K
EX-99.2
f6sn2o1lzf
12 Nov 21
Larimar Therapeutics Reports Third Quarter 2021 Operating and Financial Results
7:21am
8-K
EX-99.1
2idlc
1 Jul 21
Other Events
6:11am